ReviewTargeted oncology2012

Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies.

Annemilaï Tijeras-Raballand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.